MedKoo Cat#: 585096 | Name: R-95845

Description:

WARNING: This product is for research use only, not for human or veterinary use.

R-95845 inhibits HIV-1 reverse transcriptase.

Chemical Structure

R-95845
R-95845
CAS#163435-77-6

Theoretical Analysis

MedKoo Cat#: 585096

Name: R-95845

CAS#: 163435-77-6

Chemical Formula: C17H16Br2N2O2

Exact Mass: 437.9579

Molecular Weight: 440.14

Elemental Analysis: C, 46.39; H, 3.66; Br, 36.31; N, 6.36; O, 7.27

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
R-95845; R95845; R 95845
IUPAC/Chemical Name
Benzeneacetamide, alpha-((2-acetyl-5-methylphenyl)amino)-2,6-dibromo-,(S)-
InChi Key
FELUFXCUIYHAPB-INIZCTEOSA-N
InChi Code
InChI=1S/C17H16Br2N2O2/c1-9-6-7-11(10(2)22)14(8-9)21-16(17(20)23)15-12(18)4-3-5-13(15)19/h3-8,16,21H,1-2H3,(H2,20,23)/t16-/m0/s1
SMILES Code
O=C(N)[C@@H](NC1=CC(C)=CC=C1C(C)=O)C2=C(Br)C=CC=C2Br
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 440.14 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Shen L, Shen J, Luo X, Cheng F, Xu Y, Chen K, Arnold E, Ding J, Jiang H. Steered molecular dynamics simulation on the binding of NNRTI to HIV-1 RT. Biophys J. 2003 Jun;84(6):3547-63. PubMed PMID: 12770866; PubMed Central PMCID: PMC1302942. 2: Mestres J, Rohrer DC, Maggiora GM. A molecular-field-based similarity study of non-nucleoside HIV-1 reverse transcriptase inhibitors. 2. The relationship between alignment solutions obtained from conformationally rigid and flexible matching. J Comput Aided Mol Des. 2000 Jan;14(1):39-51. PubMed PMID: 10702924. 3: Ding J, Das K, Moereels H, Koymans L, Andries K, Janssen PA, Hughes SH, Arnold E. Structure of HIV-1 RT/TIBO R 86183 complex reveals similarity in the binding of diverse nonnucleoside inhibitors. Nat Struct Biol. 1995 May;2(5):407-15. PubMed PMID: 7545077. 4: Ding J, Das K, Tantillo C, Zhang W, Clark AD Jr, Jessen S, Lu X, Hsiou Y, Jacobo-Molina A, Andries K, et al. Structure of HIV-1 reverse transcriptase in a complex with the non-nucleoside inhibitor alpha-APA R 95845 at 2.8 A resolution. Structure. 1995 Apr 15;3(4):365-79. PubMed PMID: 7542140.